Low Disease Activity Over 4 Years of Ocrelizumab Therapy in Treatment-Naive Patients With Early-Stage Relapsing-Remitting Multiple Sclerosis; the Phase IIIb ENSEMBLE StudyRobert Bermel,Hans-Peter Hartung,Bruno Brochet,Ralph Benedict,Thomas Berger,William Carroll,Timothy Vollmer,Trygve Holmoy,Rana Karabudak,Joep Killestein,Carlos Nos,Francesco Patti,Amy Perrin Ross,Ludo Vanopdenbosch,Jens Wuerfel,Thomas Kuenzel,Karen Kadner,Inessa Kulyk,Mark FreedmanNEUROLOGY（2023）引用 0|浏览23暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
